Karen G. Spink

<scp>HER2</scp> overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the <scp>QUASAR</scp>, <scp>FOCUS</scp> and <scp>PICCOLO</scp> colorectal cancer trials

Susan D. Richman, Katie Southward, Philip Chambers et al. · The Journal of Pathology · 2015 · 231 citations · Full text

Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA

Fiona S. Togneri, Douglas G. Ward, Joseph Foster et al. · European Journal of Human Genetics · 2016 · 129 citations · Full text

The RAD51 Family Member, RAD51L3, Is a DNA-stimulated ATPase That Forms a Complex with XRCC2

Jeremy Braybrooke, Karen G. Spink, John Thacker et al. · Journal of Biological Chemistry · 2000 · 106 citations · Full text

Cross-laboratory validation of the OncoScan® FFPE Assay, a multiplex tool for whole genome tumour profiling

Joseph Foster, Assa Oumie, Fiona S. Togneri et al. · BMC Medical Genomics · 2015 · 90 citations · Full text

Uptake, Efficacy, and Systemic Distribution of Naked, Inhaled Short Interfering RNA (siRNA) and Locked Nucleic Acid (LNA) Antisense

Sterghios Moschos, Manfred Frick, B Keith Taylor et al. · Molecular Therapy · 2011 · 83 citations · Full text